Bambusa Therapeutics Prices Upsized $168.9 Million IPO

04:11 AM EDT, 10/30/2026 (MT Newswires) -- Bambusa Therapeutics (BBTX) priced an upsized initial public offering of 10,555,555 common shares at $16 apiece, for about $168.9 million in expected gross proceeds, the company said late Thursday. Underwriters have a 30-day option to purchase up to 1,583,333 additional shares. Bambusa, which is developing antibodies for immunology and inflammation, expects its shares to start trading on the Nasdaq Global Select Market under the ticker symbol BBTX Friday. The offering is expected to close Monday, the company said.